SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950123-15-002644
Filing Date
2015-02-17
Accepted
2015-02-17 13:59:56
Documents
2
Group Members
DAG VENTURES GP FUND III, LLCDAG VENTURES III, L.P.DAG VENTURES MANAGEMENT III, LLCJOHN J. CADEDDUR. THOMAS GOODRICH

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d876715dsc13g.htm SC 13G 120860
2 EX-99.1 d876715dex991.htm EX-99.1 7081
  Complete submission text file 0000950123-15-002644.txt   129767
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Subject) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88106 | Film No.: 15620803
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DAG VENTURES 251 LYTTON AVE, SUITE 200, LOWER LEVEL PALO ALTO CA 94304
Business Address C/O DAG VENTURES 251 LYTTON AVE, SUITE 200, LOWER LEVEL PALO ALTO CA 94304 650-328-2513
DAG VENTURES III-QP LP (Filed by) CIK: 0001406419 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G